Open AccessQuality of Life in Uncomplicated Symptomatic Diverticular Disease: Is It Another Good Reason for Treatment?
Author(s) -
Giuseppe Comparato,
L. Fanigliulo,
Giovanni Aragona,
Giulia Martina Cavestro,
L.G. Cavallaro,
Gioacchino Leandro,
Alberto Pilotto,
G. Nervi,
Paolo Soliani,
M Sianesi,
A. Franzè,
Francesco Di Mario
Publication year - 2007
Publication title -
digestive diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.879
H-Index - 66
eISSN - 1421-9875
pISSN - 0257-2753
DOI - 10.1159/000103896
Subject(s) - medicine , rifaximin , mesalazine , quality of life (healthcare) , diverticular disease , gastroenterology , randomized controlled trial , inflammatory bowel disease , antibiotics , disease , nursing , microbiology and biotechnology , biology
Quality of life (QoL) is becoming a major issue in the evaluation of any therapeutic intervention.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom